Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment
Clinical trial NCT06800092 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06800092
- Sponsor
- The University of Texas Medical Branch, Galveston
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2027-06-15
- Primary completion
- 2030-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.